QNTM
QNTM
NASDAQ · Pharmaceuticals

Quantum Biopharma-B Sub Vot

$2.11
-0.01 (-0.24%)
As of Nov 6, 10:19 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +350.4% upside
Low Target $6.03
Average Target $9.48
High Target $10.62
Current Price $2.11
Current
$2.11
Target
$9.48
$6.03 $9.48 avg $10.62
Scenario Analysis
Bear Case
$6.03
186.5%
Low target
Base Case
$9.48
+350.4%
Avg target
Bull Case
$10.62
+404.5%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$23.10
-90.9% from high
52-Week Low
$2.85
+-26.1% from low
Target vs 52W High
$9.48
-59.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 36 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 73% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 74% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 33 39% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 44% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 23 48% $209.87 +164.3%